Follow-up regimens for carriers of hereditary transthyretin variants
Med Clin (Barc). 2023 Mar 10;160(5):213-217.
doi: 10.1016/j.medcli.2022.10.002.
Epub 2022 Dec 16.
[Article in
English,
Spanish]
Affiliations
- 1 Internal Medicine Service, Hospital Universitario Son Llátzer, Palma, Spain; Balearic Research Group in Genetic Cardiopathies, Sudden Death and TTR Amyloidosis, Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma, Spain. Electronic address: ialosada@hsll.es.
- 2 Unidad de ELA y neuromuscular, Hospital Universitario Basurto, Bilbao, Spain.
- 3 Hospital Universitari i Politècnic La Fe & IIS La Fe, Neuromuscular Diseases Unit, Department of Neurology, Valencia, Spain; Universitat de València, Valencia, Spain; Biomedical Research Network Center in Rare Diseases (CIBERER); Member of the European Reference Network for Rare Neuromuscular Diseases (ERN EURO-NMD), Spain.
- 4 Facultativo Especialista de Área de Medicina Interna, Unidad de Enfermedades Autoinmunes, Minoritarias y Trombosis, Coordinador Unidad Multidisciplinar de Amiloidosis Hereditaria, Servicio de Medicina Interna, Hospital Juan Ramón Jiménez, Spain.
No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amyloid Neuropathies, Familial* / genetics
-
Follow-Up Studies
-
Heterozygote
-
Humans
-
Mutation
-
Prealbumin* / genetics